BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2178460)

  • 1. Immunoscintigraphic imaging of mIBG-negative metastases in neuroblastoma.
    Berthold F; Waters W; Sieverts H; Linden A
    Am J Pediatr Hematol Oncol; 1990; 12(1):61-2. PubMed ID: 2178460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
    Reuland P; Geiger L; Thelen MH; Handgretinger R; Haase B; Müller-Schauenburg W; Niethammer D; Bares R
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):437-42. PubMed ID: 11878578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-iodobenzylguanidine in children.
    Gelfand MJ
    Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
    Giammarile F; Olier AL; Lumbroso J
    Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.
    Englaro EE; Gelfand MJ; Harris RE; Smith HS
    Radiology; 1992 Feb; 182(2):515-20. PubMed ID: 1732972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
    Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
    Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
    Müller-Gärtner HW; Erttmann R; Helmke K
    Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
    Giammarile F; Lumbroso J; Ricard M; Aubert B; Hartmann O; Schlumberger M; Parmentier C
    Eur J Nucl Med; 1995 Oct; 22(10):1180-3. PubMed ID: 8542903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.